corporate_fare
First Tracks Biotherapeutics Inc.
- Address
- 10770 Wateridge Circle Suite 210
Sponsor Overview
assignment
1
sponsored trial
science
0
molecules
location_city
9
research centres
public
3
countries
person_search
9
investigators
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ANB033 in Patients with Celiac Disease |  Finland Germany The Netherlands | Recruiting |
Data & Insights
science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 0 total (0% not shared with other sponsors)
This sponsor works with 0 molecules, of which 0 are not being studied by other sponsors.
hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 9 sites collaborated multiple times
This sponsor has worked with 9 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
9 centreslocation_city
assignment126Albert Schweitzer Ziekenhuis
- Address
- Albert Schweitzerplaats 25, 3318 AT Dordrecht
location_city
assignment680Amsterdam UMC
- Address
- De Boelelaan 1117, 1081 HV Amsterdam
location_city
assignment518Center For Pediatric And Adolescent Medicine Of The Johannes Gutenberg University Mainz
- Address
- Langenbeckstrasse 1, Oberstadt, 55131 Mainz
location_city
assignment5CTC Netherlands B.V.
- Address
- Hanzeplein 1, 9713 GZ Groningen
location_city
assignment407Klinikum der Technischen Universitaet Muenchen (TUM Klinikum)
- Address
- Ismaninger Strasse 22, Au-Haidhausen, 81675 Munich
location_city
assignment178Pirkanmaan hyvinvointialue
- Address
- Elamanaukio 2, 33520 Tampere
Page 1 of 2
Want to get in touch with this sponsor?
Send a question and we'll pass it on to First Tracks Biotherapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.